Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT.

Ghazi L, Pajewski NM, Rifkin DE, Bates JT, Chang TI, Cushman WC, Glasser SP, Haley WE, Johnson KC, Kostis WJ, Papademetriou V, Rahman M, Simmons DL, Taylor A, Whelton PK, Wright JT, Bhatt UY, Drawz PE.

J Am Heart Assoc. 2019 Jul 16;8(14):e011706. doi: 10.1161/JAHA.118.011706. Epub 2019 Jul 15.

2.

Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT.

Derington CG, Gums TH, Bress AP, Herrick JS, Greene TH, Moran AE, Weintraub WS, Kronish IM, Morisky DE, Trinkley KE, Saseen JJ, Reynolds K, Bates JT, Berlowitz DR, Chang TI, Chonchol M, Cushman WC, Foy CG, Herring CT, Katz LA, Krousel-Wood M, Pajewski NM, Tamariz L, King JB; SPRINT Research Group.

Hypertension. 2019 Jul 1:HYPERTENSIONAHA11912907. doi: 10.1161/HYPERTENSIONAHA.119.12907. [Epub ahead of print]

PMID:
31256717
3.

Review of Acellular Assays of Ambient Particulate Matter Oxidative Potential: Methods and Relationships with Composition, Sources, and Health Effects.

Bates JT, Fang T, Verma V, Zeng L, Weber RJ, Tolbert PE, Abrams JY, Sarnat SE, Klein M, Mulholland JA, Russell AG.

Environ Sci Technol. 2019 Apr 16;53(8):4003-4019. doi: 10.1021/acs.est.8b03430. Epub 2019 Apr 3.

PMID:
30830764
4.

Impact of a Resident-Centered Interprofessional Quality Improvement Intervention on Acute Care Length of Stay.

Walker M, Gay L, Raynaldo G, Von Marensdorff H, Bates JT, Friedland JA, Park JH, Kehl E, Sowers B, Bhavani S, Lan C, Bozkurt B, Stewart DE, Horstman MJ.

J Healthc Qual. 2019 Jul/Aug;41(4):212-219. doi: 10.1097/JHQ.0000000000000156.

PMID:
30383558
5.

Associations of mobile source air pollution during the first year of life with childhood pneumonia, bronchiolitis, and otitis media.

Kennedy CM, Pennington AF, Darrow LA, Klein M, Zhai X, Bates JT, Russell AG, Hansen C, Tolbert PE, Strickland MJ.

Environ Epidemiol. 2018 Mar;2(1). pii: e007. doi: 10.1097/EE9.0000000000000007.

6.

Syncope, Hypotension, and Falls in the Treatment of Hypertension: Results from the Randomized Clinical Systolic Blood Pressure Intervention Trial.

Sink KM, Evans GW, Shorr RI, Bates JT, Berlowitz D, Conroy MB, Felton DM, Gure T, Johnson KC, Kitzman D, Lyles MF, Servilla K, Supiano MA, Whittle J, Wiggers A, Fine LJ.

J Am Geriatr Soc. 2018 Apr;66(4):679-686. doi: 10.1111/jgs.15236. Epub 2018 Mar 30.

PMID:
29601076
7.

Serum Bicarbonate Concentration and Cognitive Function in Hypertensive Adults.

Dobre M, Gaussoin SA, Bates JT, Chonchol MB, Cohen DL, Hostetter TH, Raphael KL, Taylor AA, Lerner AJ, Wright JT Jr, Rahman M; SPRINT Research Group.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):596-603. doi: 10.2215/CJN.07050717. Epub 2018 Mar 22.

8.

Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Pressure Intervention Trial.

Foy CG, Lovato LC, Vitolins MZ, Bates JT, Campbell R, Cushman WC, Glasser SP, Gillespie A, Kostis WJ, Krousel-Wood M, Muhlestein JB, Oparil S, Osei K, Pisoni R, Segal MS, Wiggers A, Johnson KC; SPRINT Study Research Group.

J Hypertens. 2018 Apr;36(4):904-915. doi: 10.1097/HJH.0000000000001619.

PMID:
29493562
9.

Getting it RITE: Impact of a Dedicated Hospital Medicine Curriculum for Residents.

Lin D, Shah C, Campbell S, Bates JT, Lescinskas E.

South Med J. 2018 Jan;111(1):30-34. doi: 10.14423/SMJ.0000000000000751.

PMID:
29298366
10.

Erratum: Associations between Ambient Fine Particulate Oxidative Potential and Cardiorespiratory Emergency Department Visits.

Abrams JY, Weber RJ, Klein M, Sarnat SE, Chang HH, Strickland MJ, Verma V, Fang T, Bates JT, Mulholland JA, Russell AG, Tolbert PE.

Environ Health Perspect. 2017 Dec 5;125(12):129001. doi: 10.1289/EHP3048.

11.

Associations between Ambient Fine Particulate Oxidative Potential and Cardiorespiratory Emergency Department Visits.

Abrams JY, Weber RJ, Klein M, Sarnat SE, Chang HH, Strickland MJ, Verma V, Fang T, Bates JT, Mulholland JA, Russell AG, Tolbert PE.

Environ Health Perspect. 2017 Oct 26;125(10):107008. doi: 10.1289/EHP1545. Erratum in: Environ Health Perspect. 2017 Dec 05;125(12):129001.

12.

Exposure to Mobile Source Air Pollution in Early-life and Childhood Asthma Incidence: The Kaiser Air Pollution and Pediatric Asthma Study.

Pennington AF, Strickland MJ, Klein M, Zhai X, Bates JT, Drews-Botsch C, Hansen C, Russell AG, Tolbert PE, Darrow LA.

Epidemiology. 2018 Jan;29(1):22-30. doi: 10.1097/EDE.0000000000000754.

13.

The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial).

Cho ME, Craven TE, Cheung AK, Glasser SP, Rahman M, Soliman EZ, Stafford RS, Johnson KC, Bates JT, Burgner A, Taylor AA, Tamariz L, Tang R, Beddhu S; SPRINT Study Research Group.

J Clin Hypertens (Greenwich). 2017 Nov;19(11):1152-1161. doi: 10.1111/jch.13062. Epub 2017 Sep 3.

14.

APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial.

Freedman BI, Rocco MV, Bates JT, Chonchol M, Hawfield AT, Lash JP, Papademetriou V, Sedor JR, Servilla K, Kimmel PL, Wall BM, Pajewski NM; SPRINT Research Group.

Kidney Int Rep. 2017 Jul;2(4):713-720. doi: 10.1016/j.ekir.2017.03.008. Epub 2017 Mar 31.

15.

Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).

Soliman EZ, Ambrosius WT, Cushman WC, Zhang ZM, Bates JT, Neyra JA, Carson TY, Tamariz L, Ghazi L, Cho ME, Shapiro BP, He J, Fine LJ, Lewis CE; SPRINT Research Study Group.

Circulation. 2017 Aug 1;136(5):440-450. doi: 10.1161/CIRCULATIONAHA.117.028441. Epub 2017 May 16. Erratum in: Circulation. 2017 Aug 1;136(5):e136.

16.

Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.

Upadhya B, Rocco M, Lewis CE, Oparil S, Lovato LC, Cushman WC, Bates JT, Bello NA, Aurigemma G, Fine LJ, Johnson KC, Rodriguez CJ, Raj DS, Rastogi A, Tamariz L, Wiggers A, Kitzman DW; SPRINT Research Group.

Circ Heart Fail. 2017 Apr;10(4). pii: e003613. doi: 10.1161/CIRCHEARTFAILURE.116.003613.

17.

Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus.

Wen X, Mousa JJ, Bates JT, Lamb RA, Crowe JE Jr, Jardetzky TS.

Nat Microbiol. 2017 Jan 30;2:16272. doi: 10.1038/nmicrobiol.2016.272.

18.

Baseline blood pressure control in Hispanics: characteristics of Hispanics in the Systolic Blood Pressure Intervention Trial.

Rodriguez CJ, Still CH, Garcia KR, Wagenknecht L, White S, Bates JT, Del Cid MV, Lioudis M, Lopez Barrera N, Moreyra A, Punzi H, Ringer RJ, Cushman WC, Contreras G, Servilla K, Rocco M; SPRINT Research Group.

J Clin Hypertens (Greenwich). 2017 Feb;19(2):116-125. doi: 10.1111/jch.12942. Epub 2016 Nov 14.

19.

Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.

Drawz PE, Pajewski NM, Bates JT, Bello NA, Cushman WC, Dwyer JP, Fine LJ, Goff DC Jr, Haley WE, Krousel-Wood M, McWilliams A, Rifkin DE, Slinin Y, Taylor A, Townsend R, Wall B, Wright JT, Rahman M.

Hypertension. 2017 Jan;69(1):42-50. Epub 2016 Nov 14.

20.

Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein.

Mousa JJ, Sauer MF, Sevy AM, Finn JA, Bates JT, Alvarado G, King HG, Loerinc LB, Fong RH, Doranz BJ, Correia BE, Kalyuzhniy O, Wen X, Jardetzky TS, Schief WR, Ohi MD, Meiler J, Crowe JE Jr.

Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6849-E6858. Epub 2016 Oct 17.

21.

APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.

Freedman BI, Gadegbeku CA, Bryan RN, Palmer ND, Hicks PJ, Ma L, Rocco MV, Smith SC, Xu J, Whitlow CT, Wagner BC, Langefeld CD, Hawfield AT, Bates JT, Lerner AJ, Raj DS, Sadaghiani MS, Toto RD, Wright JT Jr, Bowden DW, Williamson JD, Sink KM, Maldjian JA, Pajewski NM, Divers J.

Kidney Int. 2016 Aug;90(2):440-449. doi: 10.1016/j.kint.2016.04.027. Epub 2016 Jun 22.

22.

Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates.

Bates JT, Pickens JA, Schuster JE, Johnson M, Tollefson SJ, Williams JV, Davis NL, Johnston RE, Schultz-Darken N, Slaughter JC, Smith-House F, Crowe JE Jr.

Vaccine. 2016 Feb 10;34(7):950-6. doi: 10.1016/j.vaccine.2015.12.045. Epub 2016 Jan 7.

23.

Reactive Oxygen Species Generation Linked to Sources of Atmospheric Particulate Matter and Cardiorespiratory Effects.

Bates JT, Weber RJ, Abrams J, Verma V, Fang T, Klein M, Strickland MJ, Sarnat SE, Chang HH, Mulholland JA, Tolbert PE, Russell AG.

Environ Sci Technol. 2015 Nov 17;49(22):13605-12. doi: 10.1021/acs.est.5b02967. Epub 2015 Oct 27.

PMID:
26457347
24.

Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.

Still CH, Craven TE, Freedman BI, Van Buren PN, Sink KM, Killeen AA, Bates JT, Bee A, Contreras G, Oparil S, Pedley CM, Wall BM, White S, Woods DM, Rodriguez CJ, Wright JT Jr; SPRINT Study Research Group.

J Am Soc Hypertens. 2015 Sep;9(9):670-9. doi: 10.1016/j.jash.2015.06.012. Epub 2015 Aug 7.

25.

Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.

Galliher-Beckley A, Li X, Bates JT, Madera R, Waters A, Nietfeld J, Henningson J, He D, Feng W, Chen R, Shi J.

Vaccine. 2015 Jul 9;33(30):3518-25. doi: 10.1016/j.vaccine.2015.05.058. Epub 2015 Jun 3.

26.

STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge.

Dulek DE, Newcomb DC, Toki S, Goliniewska K, Cephus J, Reiss S, Bates JT, Crowe JE Jr, Boyd KL, Moore ML, Zhou W, Peebles RS Jr.

J Virol. 2014 Sep 1;88(17):9655-72. doi: 10.1128/JVI.03299-13. Epub 2014 Jun 11.

27.

Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein.

Bates JT, Keefer CJ, Slaughter JC, Kulp DW, Schief WR, Crowe JE Jr.

Virology. 2014 Apr;454-455:139-44. doi: 10.1016/j.virol.2014.02.010. Epub 2014 Mar 3.

28.

Emerging genetic basis of osteochondritis dissecans.

Bates JT, Jacobs JC Jr, Shea KG, Oxford JT.

Clin Sports Med. 2014 Apr;33(2):199-220. doi: 10.1016/j.csm.2013.11.004. Epub 2014 Jan 10. Review.

29.

Proof of principle for epitope-focused vaccine design.

Correia BE, Bates JT, Loomis RJ, Baneyx G, Carrico C, Jardine JG, Rupert P, Correnti C, Kalyuzhniy O, Vittal V, Connell MJ, Stevens E, Schroeter A, Chen M, Macpherson S, Serra AM, Adachi Y, Holmes MA, Li Y, Klevit RE, Graham BS, Wyatt RT, Baker D, Strong RK, Crowe JE Jr, Johnson PR, Schief WR.

Nature. 2014 Mar 13;507(7491):201-6. doi: 10.1038/nature12966. Epub 2014 Feb 5.

30.

Short- and midterm results of iliac artery stenting for flush occlusion with the assistance of an occlusive contralateral iliac artery balloon.

Bechara CF, Barshes NR, Pisimisis G, Bates JT, Lin PH, Kougias P.

Ann Vasc Surg. 2014 Jan;28(1):59-64. doi: 10.1016/j.avsg.2013.06.014. Epub 2013 Nov 1.

PMID:
24189002
31.

Wastewater management and Marcellus Shale gas development: trends, drivers, and planning implications.

Rahm BG, Bates JT, Bertoia LR, Galford AE, Yoxtheimer DA, Riha SJ.

J Environ Manage. 2013 May 15;120:105-13. doi: 10.1016/j.jenvman.2013.02.029. Epub 2013 Mar 15.

PMID:
23507249
32.

Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency.

Bates JT, Keefer CJ, Utley TJ, Correia BE, Schief WR, Crowe JE Jr.

J Immunol. 2013 Apr 1;190(7):3732-9. doi: 10.4049/jimmunol.1202964. Epub 2013 Mar 1.

33.

Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model.

Zeitlin L, Bohorov O, Bohorova N, Hiatt A, Kim DH, Pauly MH, Velasco J, Whaley KJ, Barnard DL, Bates JT, Crowe JE Jr, Piedra PA, Gilbert BE.

MAbs. 2013 Mar-Apr;5(2):263-9. doi: 10.4161/mabs.23281. Epub 2013 Feb 8.

34.

Why it's easier to remember seeing a face we already know than one we don't: preexisting memory representations facilitate memory formation.

Reder LM, Victoria LW, Manelis A, Oates JM, Dutcher JM, Bates JT, Cook S, Aizenstein HJ, Quinlan J, Gyulai F.

Psychol Sci. 2013 Mar 1;24(3):363-72. doi: 10.1177/0956797612457396. Epub 2013 Feb 8.

35.

GLAMM: Genome-Linked Application for Metabolic Maps.

Bates JT, Chivian D, Arkin AP.

Nucleic Acids Res. 2011 Jul;39(Web Server issue):W400-5. doi: 10.1093/nar/gkr433. Epub 2011 May 29.

36.

Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88.

Bates JT, Graff AH, Phipps JP, Grayson JM, Mizel SB.

J Immunol. 2011 Jun 1;186(11):6255-62. doi: 10.4049/jimmunol.1001855. Epub 2011 Apr 22.

37.

Flagellin as an adjuvant: cellular mechanisms and potential.

Mizel SB, Bates JT.

J Immunol. 2010 Nov 15;185(10):5677-82. doi: 10.4049/jimmunol.1002156. Review.

38.

MicrobesOnline: an integrated portal for comparative and functional genomics.

Dehal PS, Joachimiak MP, Price MN, Bates JT, Baumohl JK, Chivian D, Friedland GD, Huang KH, Keller K, Novichkov PS, Dubchak IL, Alm EJ, Arkin AP.

Nucleic Acids Res. 2010 Jan;38(Database issue):D396-400. doi: 10.1093/nar/gkp919. Epub 2009 Nov 11.

39.

Direct stimulation of tlr5+/+ CD11c+ cells is necessary for the adjuvant activity of flagellin.

Bates JT, Uematsu S, Akira S, Mizel SB.

J Immunol. 2009 Jun 15;182(12):7539-47. doi: 10.4049/jimmunol.0804225.

40.

Mucosal adjuvant activity of flagellin in aged mice.

Bates JT, Honko AN, Graff AH, Kock ND, Mizel SB.

Mech Ageing Dev. 2008 May;129(5):271-81. doi: 10.1016/j.mad.2008.01.009. Epub 2008 Feb 17.

41.

Knowledge and awareness of peripheral vascular disease are poor among women at risk for cardiovascular disease.

Bush RL, Kallen MA, Liles DR, Bates JT, Petersen LA.

J Surg Res. 2008 Apr;145(2):313-9. doi: 10.1016/j.jss.2007.03.022. Epub 2008 Jan 28.

PMID:
18222479
42.

Expression of a non-DNA-binding isoform of Helios induces T-cell lymphoma in mice.

Zhang Z, Swindle CS, Bates JT, Ko R, Cotta CV, Klug CA.

Blood. 2007 Mar 1;109(5):2190-7. Epub 2006 Nov 16.

44.

Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study.

Bush RL, Lin PH, Bates JT, Mureebe L, Zhou W, Lumsden AB.

J Vasc Surg. 2004 Nov;40(5):965-70.

45.

Ventilation of patients with acute lung injury and acute respiratory distress syndrome: has new evidence changed clinical practice?

Young MP, Manning HL, Wilson DL, Mette SA, Riker RR, Leiter JC, Liu SK, Bates JT, Parsons PE.

Crit Care Med. 2004 Jun;32(6):1260-5.

PMID:
15187503
46.

Coronary artery disease deaths in the Toronto Fire Department.

Bates JT.

J Occup Med. 1987 Feb;29(2):132-5.

PMID:
3819893

Supplemental Content

Loading ...
Support Center